IL-31、IL-33及其受体ST2在难治性鼻-鼻窦炎中的表达及意义

doi:10.6040/j.issn.1673-3770.0.2017.430

摘要/Abstract

摘要： 目的研究IL-31、IL-33及其受体ST2在难治性鼻-鼻窦炎(RRS)患者鼻黏膜组织中的表达,初步探讨其在RRS发病机制中的作用及意义。方法研究设立难治组、初治组及对照组。采用HE染色方法观察组织形态和检测嗜酸性粒细胞数(EOS);采用免疫组织化学法检测组织中IL-31、IL-33及ST2蛋白的相对含量;采用实时荧光定量PCR技术在mRNA水平检测IL-31、IL-33及ST2蛋白的表达;外周血检测血清总IgE的表达水平。结果 (1) 难治组、初治组的嗜酸性粒细胞数均高于对照组,难治组高于初治组;(2)免疫组织化学染色中,IL-31、IL-33在难治组、初治组及对照组均有表达,难治组、初治组表达量高于对照组,难治组高于初治组。ST2表达量难治组、初治组均高于对照组,但难治组与初治组之间差异无统计学意义;(3) 在mRNA表达水平上, IL-31、IL-33在难治组及初治组中的表达较对照组上调,难治组高于初治组;ST2表达量难治组、初治组均高于对照组,但难治组与初治组之间差异无统计学意义;(4)外周血总IgE值三组间差异无统计学意义。结论 IL-31、IL-33及其受体ST2可能在慢性鼻-鼻窦炎患者,尤其在难治性鼻-鼻窦炎患者发病机制中发挥重要作用;嗜酸性粒细胞浸润可能在难治性鼻-鼻窦炎的发展中有重要作用。

关键词: 白细胞介素31, 受体ST2, 嗜酸性粒细胞, 鼻窦炎, 难治性, 白细胞介素33

Abstract: Objective To study the expression of interleukinIL-31(IL-31), and interleukin-33(IL-33)and its receptor ST2, in the nasal mucosa of patients with refractory rhinosinusitis(RRS), and to investigate their role in the pathogenesis of RRS. Methods In this study, a refractory group, an initial treatment group, and a control group were established. The hematoxylin and eosin staining method was used to observe the morphology and detect the number of eosinophils(EOS)present in the mucosal tissues. The relative levels of IL-31, IL-33, and ST2 in the tissues were detected by immunohistological examination.Quantitative fluorescence real-time polymerase chain reaction was used to detect the mRNA levels of IL-31, IL-33, and ST2, and total serum immunoglobulin E(IgE)expression in the peripheral blood. Results (1)The number of EOS in the refractory group and initial treatment group were higher than that in the control group. Further, the number of EOS in the refractory group were higher than that in the initial group. (2) On immunohistological examination, the expression levels of IL-31 and IL-33 proteins in the refractory group and the initial treatment group were higher than those in the control group. Additionally, the expression levels of both IL-31 and IL-33were higher in the refractory group than in the initial treatment group. The expression of ST2 in the refractory group and the initial treatment group was higher than that in the control group, but there was no significant difference in the expression of ST2 between the refractory group and the initial treatment group. (3) At the level of mRNA expression, the levels of IL-31 and IL-33 in the refractory group and the initial treatment group were higher than those in the control group. Furthermore, the levels of IL-31 and IL-33 mRNA in the refractory group were higher than those in the initial treatment group. The ST2 mRNA levels in the refractory group and the initial treatment group were higher than that in the control group, but there was no significant difference between the refractory group and the initial treatmentgroup. (4) There was no significant difference between the three groups in the total IgE levels in the peripheral blood. Conclusion IL-31, and IL-33 along with its receptor ST2, may play an important role in the pathogenesis of chronic rhinosinusitis, especially in patients with RRS. Eosinophilic infiltration may also play an important role in the development of RRS.

Key words: Sinusitis, refractory, Receptor ST2, Eosinophils, Interleukin 33, Interleukin 31

中图分类号:

R765.4

张俐悦,刘金兰,姚东方,李杰恩. IL-31、IL-33及其受体ST2在难治性鼻-鼻窦炎中的表达及意义[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 37-41.

ZHANG Liyue, LIU Jinlan, YAO Dongfang, LI Jieen. The expression and significance of interleukin-31, and interleukin-33 and its receptor ST2, in refractory rhinosinusitis[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 37-41.

参考文献

[1] 王成硕,张罗. 慢性鼻窦炎的治疗策略[J]. 临床耳鼻咽喉头颈外科杂志,2016,30(14):1175-1178. WANG Chengshuo, ZHANG Luo. Management of chronic rhinosinusitis[J]. J Clin Otorhinolaryngol Head Neck Surg, 2016, 30(14):1175-1178.
[2] 韩德民. 难治性鼻及鼻窦炎[J]. 中国医学文摘(耳鼻咽喉科学),2010,25(2):59-62. [2017-09-15].
[3] 董革辉,魏培,黄俊琼,等. IL-31单克隆抗体的制备及ELISA检测方法的建立[J]. 中国免疫学杂志,2014,30(4):495-498. DONG Gehui, WEI Pei, HUANG Junqiong, et al. Preparation of monoclonal antibodies against IL-31 and development of sandwich ELISA for IL-31[J].Chin J Immunol, 2014, 30(4):495-498.
[4] Schmitz J, Owyang A, Oldham E, et al. IL-33,an interleukin-l-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines[J]. Immunity, 2005, 23(5):479-490.
[5] Dalm VA, de Wit H, Drexhage HA. Thymosin α 1: a novel therapeutic option for patients with refractory chronic purulent rhinosinusitis[J]. Ann N Y Acad Sci, 2012, 1270:1-7.
[6] Desrosiers M. Refractory chronic rhinosinusitis: pathophysiology and management of chronic rhinosinusitis persisting after endoscopic sinus surgery[J]. Curr Allergy Asth Reports, 2004, 4(3):200-207.
[7] Fokkens W,Lund V,Mullol J,et al. European position paper on rhinosinusitis and nasal polyps 2007[J].Rhinol Suppl, 2007, 20: 1-136.
[8] Baumann R, Rabaszowski M, Stenin I, et al. The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms[J]. Clin Transl Allergy, 2012, 2(1):13.
[9] 高雅倩,黄俊琼. 白介素31及其受体在过敏性呼吸道疾病中的作用[J]. 现代医药卫生,2015,31(19):2945-2947.
[10] 刘天聪, 吕昌龙, 曹志伟. IL-33及其受体ST2在伴鼻息肉的慢性鼻-鼻窦炎中的表达及意义[J]. 临床耳鼻咽喉头颈外科杂志, 2015,29(15):1350-1353. LIU Tiancong, LV Changlong, CAO Zhiwei. Expression and role of IL-33and its receptor ST2in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps[J].J Clin Otorhinolaryngol Head Neck Surg, 2015, 29(15):1350-1353.
[11] 郑霞, 邓丹立, 杨辉红. 嗜酸性粒细胞增多与临床[J]. 实用医技杂志, 2008, 15(5): 654-656.
[12] 王节,纪东,桂晓钟. 嗜酸性粒细胞在慢性鼻-鼻窦炎发病中表现的探讨[J]. 中国中西医结合耳鼻咽喉科杂志,2017,25(2):91-93. WANG Jie, JI Dong, GUI Xiaozhong. Study of eosinophils in the pathogenesis of chronic rhinosinusitis[J].Chin J Otorhinolaryngol Integrative Med, 2017, 25(2):91-93.

相关文章 15

[1]	宋晓宇, 张宇, 李成林, 宋西成. 加速康复外科理念在慢性鼻-鼻窦炎伴鼻息肉手术治疗中的应用[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 9-12.
[2]	张汝祥,田昊,马有祥. 鼻内镜鼻窦手术前筛窦颅底高度的CT评估价值[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 75-77.
[3]	王驰,刘星,孔磊,洪兴和,宁博. 鼻内镜下等离子射频消融术对合并鼻窦炎的小儿腺样体肥大患者疗效及鼻腔黏膜纤毛清除功能的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 78-81.
[4]	吴喜福, 孔维封, 王玮豪, 徐惠清, 戚敏, 杨钦泰. QoR-15在加速康复外科改善慢性鼻-鼻窦炎伴鼻息肉围手术期生活质量评估中的应用[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 5-8.
[5]	乔叔芬,杨飞轮,王臻妮,李学忠. YKL-40与慢性鼻-鼻窦炎组织重构的相关性探讨[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 95-99.
[6]	陈望兴,赵雪,刘岩,刘悦,金春顺. 鼻中隔偏曲及慢性鼻窦炎鼻息肉患者的精神心理状态调查[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 24-27.
[7]	黄凯丰. 糖皮质激素短疗程雾化吸入对嗜酸粒细胞性鼻窦炎伴鼻息肉患者鼻部症状及肾上腺皮质功能的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 28-31.
[8]	陈鸣,俞雪飞. 浅谈伴有变应性鼻炎的慢性鼻窦炎的治疗[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 18-22.
[9]	娄鸿飞,王成硕. 慢性鼻窦炎分型研究进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 10-13.
[10]	李华斌, 赖玉婷. 慢性鼻-鼻窦炎的发病机制及诊疗进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 4-9.
[11]	张桂敏,林鹏. 慢性鼻-鼻窦炎的内在型:从基础到临床[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 14-17.
[12]	张炜,曾昱菡,余先崧. 慢性鼻窦炎手术前后ECP、EGF、IL-6的水平变化及临床意义[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 63-67.
[13]	李莹. 慢性鼻窦炎的辨证论治[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 27-30.
[14]	李宏梅,王兰,高照慧,王莹,薛金梅. p-ERK2及ERK2在鼻息肉组织的表达及其意义[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 42-46.
[15]	张劼,龚齐. 不同分型慢性鼻-鼻窦炎患者外周血嗜酸性粒细胞与中性粒细胞百分比及变态反应临床差异性分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 54-57.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed